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Abstract
Increased reactive oxygen species (ROS) and hyperlipidemia can promote arterial thrombus. We
evaluated the potential of a partially hydrolyzed guar gum (PHGG) as dietary fiber on lipid profiles
and FeCl3-induced arterial thrombosis in the high fat-diet fed hamsters. Our in vitro results found
that PHGG is efficient to scavenge O2
-•, H2O2, and HOCl. High fat-diet increased plasma
triglyceride, total cholesterol, LDL, VLDL, methylguanidine and dityrosine level and accelerated
FeCl3-induced arterial thrombosis formation (from 463 ± 51 to 303 ± 45 sec). Low dose PHGG
supplement significantly decreased the total cholesterol, LDL, methylguanidine and dityrosine level
and delayed the time for arterial thrombosis formation (528 ± 75 sec). High dose PHGG
supplement decreased the level in triglyceride, total cholesterol, LDL and VLDL and further
delayed the time for arterial thrombus (671 ± 36 sec). The increased Bax protein and decreased
Bcl-2 and HSP-70 protein expression was found in the carotid and femoral arteries of high fat-diet
hamsters. Low and high dose of PHGG supplement decreased Bax expression and increased Bcl-2
and HSP-70 protein expression. We found that FeCl3 significantly enhanced intercellular adhesion
molecule-1 and 4-hydroxynonenal expression in the endothelial site of damaged artery after 150-
sec FeCl3 stimulation. PHGG supplement decreased the endothelial ICAM-1 and 4-hydroxynonenal
expression after 150-sec FeCl3 stimulation. Based on these results, we conclude that PHGG
supplement can increase antioxidant protein expression and thus decrease oxidative stress induced
arterial injury.
Background
It is generally accepted that excess reactive oxygen species
(ROS) production can cause oxidation of biological mac-
romolecules and produce damage to biological systems
[1-5]. The major ROS like O2
-., H2O2 and HOCl, which
can produce lipid peroxidation products, malonealde-
hyde and phosphatidylcholine hydroperoxide [3,6] and
protein oxidation, dityrosine and methylguanidine, as
indirect indicators of ROS and/or free-radical activity
[6,7]. Locally enhanced vascular production of ROS
decreases the bioavailability of nitric oxide, impairs vascu-
lar relaxation, and promotes leukocytes and platelet adhe-
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sion/aggregation [8]. On the other hand, increased levels
of cholesterol or lipid profiles in the plasma is a status
called hyperlipidemia, which can lead to serious prob-
lems such as coronary heart disease and other cardiovas-
cular diseases [9]. There is evidence that adhesion of
monocytes to the endothelium and transformation of
macrophages into foam cells, plaque stability, vasomotor
function, platelet aggregation and tendency to thrombosis
lead to the development of atherosclerosis and coronary
artery disease and can be modified by antioxidants
[10,11]. Therefore, a dynamic interaction exists between
endothelial and thrombosis/atherogenesis, both of which
may be influenced by oxidative stress and lipid profiles.
Adhesion of platelet and leukocytes into the vascular
endothelial cell by the increased expression of intercellu-
lar adhesion molecule-1 (ICAM-1) is a crucial step in
thrombosis/atherogenesis [12]. Suppressed expression of
ICAM-1 was associated with reduced adherence of mono-
cytes, lymphocytes and platelets to oxidized LDL stimu-
lated endothelial cells [13,12]. The defense of vascular
endothelium against the damage caused by ROS and dys-
lipidemia is probably an important factor for reduction of
thrombotic and atherosclerotic attack [10]. Vascular wall
protection can be achieved by preventive attachment to
the vascular wall of antioxidants and elimination/neutral-
ization of toxic products after their disproportioning
[14,15].
Lipid-lowering strategy may have a beneficial role in nor-
malizing vascular function and greatly decreasing the fre-
quency of clinical events associated with atherosclerosis,
combined with the ability of antioxidants to alleviate vas-
omotor disturbances in hypercholesterolemia and to slow
the progression of atherosclerosis [3]. There is an increase
in interest in finding a naturally antioxidant plant-based
compound, which could reduce the increased lipid levels
in plasma. Guar gum, a galactomannan derived from the
cluster bean of Cyamopsis tetragonolobus which is culti-
vated in India, Pakistan, and the United States, and its
enzymatic hydrolysate (partially hydrolysed guar gum,
PHGG) shown in Figure 1 have been shown to decrease
levels of serum cholesterol and lipids and postprandial
blood glucose [16]. The present study was carried out in
hamsters adapted to high-fat diet to compare the lipid-
lowering effectiveness of PHGG and to examine the
impact of PHGG supplement on FeCl3-induced acute arte-
rial injury in the animals. The antioxidant activity and
mechanism in PHGG on FeCl3 induced arterial thrombo-
sis was also evaluated in the present study.
Methods and materials
Changes of lucigenin- and luminol-enhanced 
chemiluminescence counts (CL)
We evaluated the antioxidant activity of PHGG on xan-
thine (0.75 mg kg-1, dissolved in 0.01 N NaOH) and xan-
thine oxidase (24.8 mU kg-1) enhanced O2
-., 0.03% H2O2
induced H2O2 activity, and 0.03% HOCl induced HOCl
activity. Xanthine and xanthine oxidase were purchased
from Sigma, USA. ROS levels were measured by a CL ana-
lyzing system (CLD-110, Tohoku Electronic Industrial,
Sendai, Japan) as described previously (7). The system
contains a photon detector (Model CLD-110), CL counter
(Model CLC-10), water circulator (Model CH-200) and
32 bit IBM personal computer system. A cooler circulator
is connected to the model CLD-110 photon detector to
keep the temperature at 5°C. The CLD-110 model is
extremely sensitive; it is able to detect as little as 10-15 W
of radiant energy. The CL was measured in an absolutely
dark chamber of the CL analyzing system. We demon-
strated that using CL-emitting substance lucigenin (N, N'-
dimethyldiacridinium, Sigma, St. Louis, MO, USA) for O2
-
. or luminol (5-amino-2,3-dihydro-1,4-phthalazinedione,
Sigma, St. Louis, MO, USA) for H2O2 or HOCl (hydrogen
peroxide, sodium hypochlorite, Sigma, St. Louis, MO,
Chemical structure of partially hydrolysed guar gum (PHGG) Figure 1
Chemical structure of partially hydrolysed guar gum (PHGG). The chemical structure of PHGG: mannose: 
galactose = 2:1.Journal of Biomedical Science 2009, 16:15 http://www.jbiomedsci.com/content/16/1/15
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USA) to enhance the CL counts provided similar data to
those reported in our previous study [1,3]. The lucigenin-
enhanced CL method provides a reliable assay for super-
oxide. After 100 s, 1.0 ml of 0.1 mM lucigenin in PBS (pH
= 7.4) was mixed with the tested sample. The CL in the
tested sample was measured continuously for a total of
600 s. The assay was performed in duplicate for each sam-
ple, and the results are expressed as CL counts (10 s)-1. The
total amount of CL in 600 s was calculated by integrating
the area under the curve. The mean ± S.E.M. CL level for
each sample was calculated.
Animals
Golden Syrian hamster (Mesocricetus auratus), male 12-
week old, 110–120 g body weight were used and were
housed at the Experimental Animal Center, National Tai-
wan University. A group of eight animals (four/cage) were
kept in controlled conditions, temperature 25–26°C, rel-
ative humidity 60–80% and 12/12 h light/dark cycle
(light from 8.00 a.m. to 8.00 p.m.). Food and water were
provided ad libitum. The animals with identification
marks were acclimatized for 7 days before experiments.
All surgical and experimental procedures were approved
by National Taiwan University College of Medicine and
College of Public Health Institutional Animal Care and
Use Committee and are in accordance with the guidelines
of the National Science Council of Republic of China
(NSC 1997).
The high-fat diet (HF) was prepared by mixing the normal
pellet diet with groundnut oil, cholesterol (Sigma), deox-
ycholesterol (Sigma), and fructose (Sigma) in a ratio of
610 g:300 ml:5 g:5 g:100 g, respectively, to a final weight
of 1.0 kg. This homogenous soft cake was molded in the
shape of pellets of about 3 g each. The average caloric
intake is estimated from the control diet and high fat diet,
respectively. Animals of all the groups were fed with HF
(10 g/animal) for 4 days before PHGG treatment. The ani-
mals had free access to HF and water for 28 days (days 1–
28). Subsequently they were randomly divided into four
groups (n = 11 each); Group 1: animals received normal
powdered rodent diet (control) (purchased from LabDiet,
Nutrition International Inc. USA); Group 2:, animals
received HF; Group 3 and 4: 0.25 mg (HFLP) and 1.0 mg
PHGG (HFHP) were administered in the animals received
HF. PHGG was supplied by Taiyo Kagaku Co., Ltd., Japan.
Collection of blood samples and biochemical analysis from 
plasma
The collection of blood was made on day 28, 2 h after the
last PHGG administration. Hamsters (non-fasted) were
anesthetized by sodium pentobarbital (50 mg/ml in nor-
mal saline), injected i.p. (1 ml/kg body weight). Blood
was drawn from the jugular vein and collected in EDTA-
coated tubes (3 mg/ml) by centrifugation at 1,500 × g for
5 min at 4°C for the estimation of plasma total choles-
terol, triglycerides, and high-density lipoprotein (HDL),
LDL, very low-density lipoprotein (VLDL), and choles-
terol values were measured [3]. The measurement of lipo-
protein(a) [Lp(a)] was performed with a commercial LPA
kit (#465360, Beckman Coulter-Array System, Denmark).
The analysis of plasma biochemical parameters was per-
formed on an auto-analyzer of Beckman Coulter model,
'Synchron-CX-5 Clinical System' by standard enzymatic
methods, and assay kits were purchased from Beckman
Coulter International USA.
FeCl3 induced acute arterial thrombosis
All the animals were anesthetized by subcutaneous injec-
tion of 1.2 g/kg urethane (Sigma-Aldrich Inc., St. Louis,
MO, USA). A PE-50 catheter was catheterized in the fem-
oral vein for intravenous administration of tested saline
by an infusion pump (Infors AG, CH-4103, Bottmingen,
Switzerland) at a rate of 1.2 ml/min. After arterial isola-
tion, transonic flow probes (Probe# 0.5VBB517, Tran-
sonic Systems Inc., Ithaca, NY, USA) for carotid arterial
blood flow measurement were applied and were dis-
played on a small animal blood flow meter (Model 206,
Transonic Systems Inc., Ithaca, NY, USA). All the blood
flow signals were continuously recorded by an ADI system
(PowerLab/16S, ADI Instruments, Pty Ltd, Castle Hill,
Australia). The carotid artery was injured as previously
described [11] with slight modification. A filter paper (1
mm × 2 mm) soaked with 30% FeCl3 solution (Ferric
chloride, Sigma, St. Louis, MO, USA), was applied to the
artery for 3 minutes and the cavity was filled with saline
immediately [11]. The FeCl3 solution easily diffused into
the arterial tissue induced a Fenton reaction mediated
endothelial injury (impairment of nitric oxide release)
and subsequently induce vascular constriction to reduce
arterial blood flow within minutes [11]. The flow rate was
monitored and recorded and the time to occlusion (TTO,
arterial blood flow decreases to zero) was determined.
4-HNE products and ICAM-1 expression in the carotid 
artery
We considered that the high levels of FeCl3 via Fenton
reaction enhanced ROS might promote the expression of
ICAM-1 and the accumulation of lipid peroxides, 4-
hydroxynonenal (4-HNE) in the endothelium for induc-
tion of thrombosis within minutes. We evaluated the
expression of 4-HNE and ICAM-1 after 150 sec of FeCl3
stimulation in four groups of hamsters (n = 3 in each
group). 4-hydroxynonenal (4-HNE) [5] and ICAM-1
expression [17] in the OCT-embedded sections of vascular
rings were immunostained. On the day of staining, we
removed the frozen slides from -20°C and thawed at
25°C for 30 min. After rinsing in 0.2 mol/L of phosphate
buffer saline (PBS), the sections were incubated in 3%
hydrogen peroxide in 0.2 mol/L of PBS for 30 min, fol-Journal of Biomedical Science 2009, 16:15 http://www.jbiomedsci.com/content/16/1/15
Page 4 of 10
(page number not for citation purposes)
lowed by incubation in blocking buffer (5% goat serum,
0.25% Triton-X, 1% dry milk in 0.2 mol/L PBS) for 1 h,
followed by the exposure to specific primary antibody.
The 30-m cross sections were stained immunohisto-
chemically for presence of in vivo markers of lipid perox-
idation, 4-HNE-protein adducts, by incubation with a
polyclonal antibody (Alpha Diagnostic International; San
Antonio, TX, USA) and antibody raised against ICAM-1
(R&D Systems, Minneapolis, MN, USA) diluted at 1:50
overnight. The following day, sections were incubated for
2 h at 25°C with biotinylated goat-anti-rabbit secondary
antibody (1:200, vector ABC-AP kit; vector Labs, Burlin-
game, CA, USA). The sections were stained with an avidin-
biotinylated horseradish-peroxidase procedure using a
commercially available kit (ABC Elite; Vector Laborato-
ries). Finally, the color was developed by the 3'-Amino-9-
ethylcarbazole substrate (Vector Laboratories). The 4-
HNE and ICAM-1 stains were photographed on an Leica
microscope (model DMRD, Leica Microsystems Wetzlar,
Wetzlar, Germany). The expressed percentage of endothe-
lial 4-HNE and ICAM-1 expression was analyzed by the
curvature of circular stain/360° × 100%. The percentage
of 4-HNE and ICAM-1 expression in the vascular ring was
calculated as following formula.
Immunoblot analysis of antioxidant- and anti-apoptosis-
related proteins
Antibodies raised against mouse anti-human Bcl-2 (Trans-
duction, Bluegrass-Lexington, KY, USA), Bax (Chemicon,
Temecula, CA, USA) and primary polyclonal rabbit anti-
human HSP-70 (Transduction, Bluegrass-Lexington, KY,
USA) antibodies were diluted at 1:400. (BioVision, Moun-
tain View, CA, USA), and -actin (Sigma) were used. Pro-
teins on SDS-PAGE gels were transferred to nitrocellulose
filters and stained as described previously [1]. The density
of the band with the appropriate molecular mass was
determined semi-quantitatively by densitometry using an
image analyzing system (Alpha Innotech, San Leandro,
CA). The ratio of HSP70 and Bcl-2 and respective -actin
density was used to compare among groups.
Statistical analyses
All values were expressed as mean ± standard error mean
(SEM). Differences within groups were evaluated by
paired t-test. One-way analysis of variance was used for
establishing differences among groups. Intergroup com-
parisons were made by Duncan's multiple-range test. Dif-
ferences were regarded as significant if P  < 0.05 was
attained.
Results
Effect of PHGG on scavenging O2
-., H2O2 and HOCl 
activity
We first compared the antioxidant O2
-., H2O2, HOCl activ-
ity of PHGG in 10 g/mL. We found that the ability in
scavenging O2
-., H2O2 and HOCl activity by PHGG, cate-
chins, vitamin C and distilled water was displayed in an
order of catechins > vitamin C > PHGG > distilled water as
a control value (Figure 2).
Effect of PHGG on caloric intake and body weight gain
Our results showed that HF significantly (P  < 0.05)
increased the caloric intake and increased body weight
gain in the HF, HFLP and HFHP groups when compared
to the control group. Two dosages of PHGG did not signif-
icantly decrease caloric intake and growth of animals fed
with HF (Figure 3). However, there is a tendency for HFLP
and HFHP in the reduction of caloric intake and body
weight gain.
The antioxidant activity against O2•-, H2O2, HOCl in control  (distilled water), PHGG, catechins and vitamin C is demon- strated Figure 2
The antioxidant activity against O2•-, H2O2, HOCl in 
control (distilled water), PHGG, catechins and vita-
min C is demonstrated. Catechins, vitamin C and 
PHGG significantly reduced O2•-, H2O2, HOCl activ-
ity in an order of catechins > vitamin C > PHGG > 
control. Each test was performed 6 times. * P < 0.05 when 
compared to the control value.Journal of Biomedical Science 2009, 16:15 http://www.jbiomedsci.com/content/16/1/15
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Effect of PHGG on carolic intake and the increased body weight in the four groups of animals Figure 3
Effect of PHGG on carolic intake and the increased body weight in the four groups of animals. Each group was 
performed in 11 animals. * P < 0.05 when compared to the control value or 0 week, respectively.Journal of Biomedical Science 2009, 16:15 http://www.jbiomedsci.com/content/16/1/15
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PHGG decreased lipid profiles and oxidative stress
The lipid profiles in the four groups of animals are dis-
played in the Table 1. We found that four weeks of HF sig-
nificantly increased TG, T-CHO, HDL, LDL and VLDL, but
not LP(a) level with comparison to the control group. Low
dose of PHGG significantly reduced HF-enhanced T-CHO
and LDL level, whereas high dose of PHGG significantly
depressed HF-enhanced TG, T-CHO, LDL and VLDL lel-
vel.
On the other hand, oxidative stress indicated by methyl-
guanidine and dityrosine is also significantly elevated in
the HF group when compared to the control group. HFLP
and HFHP efficiently reduced these oxidative markers
when compared to the HF group.
PHGG attenuated FeCl3 induced arterial injury
At the indicated time of 150 sec-FeCl3 stimulation, we
observed that enhanced 4-HNE (Figure 4B) and ICAM-1
expression (Figure 4F) was noted in the endothelial site of
the damaged carotid artery in the HF group when com-
pared to the control group. We found that FeCl3 induced
arterial injury evaluated by TTO was 463 ± 51 sec in the
control group, 303 ± 45 sec in the HF group, 528 ± 75 sec
in the HFLP and 671 ± 36 sec in the HFHP group, respec-
tively (Figure 4I). HF significantly (P < 0.05) promoted
the arterial thrombosis formation when compared to the
control group. Low and high dose of PHGG significantly
attenuated FeCl3 induced arterial injury by the increased
TTO.
PHGG increased Bcl-2 and HSP-70, but decreased Bax 
protein expression
As shown in Figure 5, we found that after four weeks of HF
diet significantly decreased the Bcl-2 and HSP-70 and
enhanced Bax protein expression in the carotid artery and
femoral artery. The enhanced Bax and decreased Bcl-2
expression significantly amplified the Bax/Bcl-2 ratio and
possibly contributed to FeCl3  induced carotid arterial
injury. PHGG treatment preserved the decrease in Bcl-2
and HSP-70 expression and diminished the enhancement
in Bax expression in the carotid artery and femoral artery.
Also, a further increase in PHGG supplement seems to
enhance the Bcl-2 and HSP-70 expression in the carotid
and femoral arteries.
Discussion
We found that an antioxidant O2
-., H2O2, HOCl activity
was displayed in an order of catechins > vitamin C >
PHGG when compared to the water control. The novel
biological function of PHGG as a O2
-., H2O2, and HOCl
scavenger was first demonstrated in the present study. The
combined effect of lipid-lowering and antioxidant activity
by 4 weeks of PHGG supplement contributes to the reduc-
tion of blood lipids and oxidative stress and the delay of
arterial thrombus by the upregulation of endogenous
antioxidants and downregulation of ICAM-1.
Guar gum with viscous hydrocolloids may reduce the rate
of gastric emptying and the diffusion of nutrients to the
mucosa of the small intestine and increase cecal output
[18]. For example, guar gum changed bile acid pools and
intestinal reabsorption to lower cholesterols [19] and
decreased trichloroethylene accumulation in the body by
Table 1: Lipid profiles and oxidative stress in the four groups of hamsters.
Group
Parameters Control (n = 11) HF
(n = 11)
HFLP (n = 11) HFHP (n = 11)
TG
(mg/dl)
44.5 ± 11.1 98.9 ± 17.4* 88.3 ± 13.5* 47.9 ± 11.1#
T-CHO
(mg/dl)
72.9 ± 2.8 110.5 ± 7.1* 89.7 ± 4.7*# 77.2 ± 1.7#
HDL
(mg/dl)
46.2 ± 1.9 51.9 ± 1.8* 52.9 ± 2.0* 54.6 ± 0.8*
VLDL
(mg/dl)
8.4 ± 2.2 19.6 ± 3.5* 17.7 ± 2.7* 9.6 ± 2.2#
LDL
(mg/dl)
18.5 ± 1.3 39.3 ± 5.7* 16.9 ± 3.9# 14.3 ± 1.4*#
LP(a)
(mg/ml)
4.8 ± 0.6 6.1 ± 0.5 4.6 ± 0.3 5.8 ± 0.5
MG 89.8 ± 4.8 105.0 ± 4.3* 89.3 ± 4.8# 94.4 ± 8.2#
Dityrosine 1064.1 ± 59.6 1359.4 ± 51.5* 1067.9 ± 45.5# 1002.5 ± 60.0#
Control, feeding with regular diet; High-fat diet (HF), feeding with high-fat diet; High-fat diet + low dose of PHGG (0.25 mg/hamster, HFLP); High-
fat diet + high dose of PHGG (1.0 g/hamster, HFHP). Data are shown as mean ± standard error mean. * P < 0.05 vs. Control group; # P < 0.05 vs. 
HF group.Journal of Biomedical Science 2009, 16:15 http://www.jbiomedsci.com/content/16/1/15
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reducing trichloroethylene absorption and fat tissue mass
[20]. In our study, PHGG supplement seems to have a ten-
dency to depress HF increased caloric intake. However,
PHGG supplement didn't significantly decrease body
weight gain when compared to the HF group without
PHGG supplement. Previous study showed that guar gum
in semisolid meal resulted in a more moderate change in
blood glucose and positively affected satiety, while gen-
eral appetite, total energy intake and meal pattern did not
differ [21]. Further data also supported there were no sig-
nificant differences in body weight between control rats
and rats fed the guar gum diets [22]. It has been suggested
that PHGG with a reduction in viscosity by partial hydrol-
ysis, its efficiency may be greatly diminished [23,24]. Yet,
several reports have indicated that PHGG like guar gum
efficiently increases bile acid secretion and leads to a cho-
lesterol-lowering effect in rats fed high-fat diet [21,24,25].
The mechanism for an insignificant effect of PHGG on
body weight gain requires further investigation in future.
Dietary cholesterol and fat is well known to elicit an accu-
mulation of cholesterol esters and triglycerides in the liver
possibly via an enhancement of cholesterol-7 hydroxy-
lase activity for bile acid synthesis, and a suppression of
Effect of PHGG on 30% FeCl3-induced 4-HNE, ICAM-1 and TTO in the injuried carotid artery of the hamsters with HF diet Figure 4
Effect of PHGG on 30% FeCl3-induced 4-HNE, ICAM-1 and TTO in the injuried carotid artery of the hamsters 
with HF diet. Oxidative stress indicated by 4-HNE (A-D) and ICAM-1 (E-H) immunostaining of hamster carotid arterial sec-
tions subjected to 150 sec of FeCl3-induced arterial injury. Significantly enhanced endothelial ICAM-1 (brown color in B) and 
and 4-HNE (brown color in F) are found in HF group subjected to FeCl3 treated carotid artery. The amplified diagram in the 
right corner was displayed. Carotid arterial 4-HNE and ICAM-1 expression were significantly reduced in HFLP and HFHP 
groups. FeCl3 induced time to occlusion (TTO) of carotid arteries obtained from control (n = 11), HF (n = 11), HFLP (n = 11) 
and HFHP (n = 11) groups is indicated in the I. HF shortened TTO, but was reversed by PHGG treatment. *P < 0.05 vs. control 
group. # P < 0.05 vs. HF group.Journal of Biomedical Science 2009, 16:15 http://www.jbiomedsci.com/content/16/1/15
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Effect of low and high dosage of PHGG on Bax, Bcl-2, and HSP-70 expression in the carotid artery and femoral artery of HF fed  hamsters Figure 5
Effect of low and high dosage of PHGG on Bax, Bcl-2, and HSP-70 expression in the carotid artery and femoral 
artery of HF fed hamsters. HF increased Bax and decreased Bcl-2 and HSP-70 expression in the hamster carotid and femo-
ral arteries. HFLP and HFHP treatment decreased Bax and increased Bcl-2 and HSP-70 expression in both carotid and femoral 
arteries. *P < 0.05 vs. control group. # P < 0.05 vs. HF group.Journal of Biomedical Science 2009, 16:15 http://www.jbiomedsci.com/content/16/1/15
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HMG-CoA reductase activity for rate-limiting cholesterol
synthesis, contributing to hyperlipidemia [19]. The sup-
plementation of PHGG to lower the intestinal uptake of
fat and cholesterol is an interesting strategy to reduce the
risk of vascular disease. Our results showed that PHGG
significantly decreased blood lipid profiles in the HF fed
hamsters. Several mechanisms could be involved. Intake
of 3–6% PHGG decreases the bioaccessibility of both fat
and cholesterol through the depletion flocculation mech-
anism to inhibit bile salt induced emulsification and
decreases lipolytic activity in the healthy volunteers [25].
PHGG supplement accelerated oxidation of cholesterol
toward bile acids accompanied by a marked reduction in
hepatic cholesterol and enhanced HMG-CoA reductase
activity in the rat [18]. Other notion has also indicated
that accelerated cecal bile acid absorption and steroid
fecal excretion appear to accompany a greater intestinal
bile acid absorption and portal flux to the liver [19].
PHGG can bind the components of micelles in the small
intestine: bile acids, but also phospholipids or cholesterol
[26]. These mechanisms implicated that PHGG or guar
gum contributed to a strong antidyslipidemic potential
[23-25]. In our study, low dose of PHGG decreased HF
enhanced T-CHO and LDL levels, whereas high dose of
PHGG further depressed HF-enhanced TG, T-CHO, LDL
and VLDL level in the hamsters fed with HF diets. Both
low and high dose of PHGG decreased total cholesterol
and LDL. High dose of PHGG exerts more efficient in
reduction triglyceride, total cholesterol, LDL, and VLDL
level. The present study provides important information
that 4 weeks of PHGG supplement can ameliorate HF
induced hyperlipidemia.
Guar gum administration combats oxidative stress result-
ing in a trend to lower oxidative modification of LDL [27].
This data implicate that PHGG obtained from guar gum
may have a direct antioxidant activity against oxidative
stress. We have used a well-established enhanced CL
method for measurement of various types of ROS genera-
tion [1-5]. This method has been applied for measure-
ment of ROS production in cultured cells, the whole-
blood system, isolated perfused organs, urinary bladder,
and kidney in vivo [1-5]. Our evidence indicated that the
enhanced level of O2
-., H2O2, HOCl was significantly
depressed by PHGG. In addition, we found that the
enhanced antioxidant defense mechanism of Bcl-2 and
HSP-70 and the depressed apoptotic/oxidant mechanism
of Bax expression were noted after 4 weeks of PHGG sup-
plement. Low and high dose of PHGG supplement for
four weeks significantly reduced plasma methylguanidine
and dityrosine levels, two oxidative stress markers, in the
HF fed hamsters. We also found that FeCl3 treatment sig-
nificantly increased 4-HNE accumulation, a lipid proxida-
tion product, in the endothelial site of carotid artery,
indicating oxidative injury existing in the vascular area.
PHGG supplement reduced 4-HNE production in the
damaged endothelium.
Increased ROS can also trigger the translocation of NF-B
and AP-1 to nucleus and activation of inflammatory
cytokines and ICAM-1 that, in turn, contributes to further
production of ROS by leukocyte adhesion and inflamma-
tion [28]. Enhanced ICAM-1 expression in the endothelial
site can increase leukocyte adhesion and platelet aggrega-
tion and promoted thrombus formation of the injured
vessel [11,15,28]. We found that HF fed animals are asso-
ciated with the increase of oxidative stress and subse-
quently promoted FeCl3  induced arterial thrombus
formation and the impairment of vascular integrity. Our
data showed that four weeks of PHGG supplement signif-
icantly down regulated ICAM-1 expression in the
endothelial site of the FeCl3 treated carotid artery and sig-
nificantly delayed the time of FeCl3-induced occlusive
arterial thrombus in a dose-dependent manner. The ben-
eficial effect could be due to the synergistic effect of a
upregulation in antioxidant Bcl-2 and HSP-70 protein, a
suppression of endothelial ICAM-1 protein expression,
and a reduction in leucocyte and platelet adhesion, conse-
quently leading to the delay of FeCl3 induced thrombus
formation in the vascular endothelium of HF fed ham-
sters.
PHGG supplement decreased cholesterol and lipid levels
and oxidative stress and thus has a potential to prevent
hypertension and cardiovascular diseases [22,29,30].
After 50 days of PHGG administration, attenuation of uri-
nary protein excretion, total cholesterol level and the mor-
phological changes peculiar to diabetic nephropathy were
observed in the rats [16]. Moreover, PHGG can delay the
elevation of blood sugar and potentially control the blood
sugar in the diabetic patients [31]. Based on these evi-
dences, we implicate that PHGG had a potential in reduc-
tion of cardiovascular attack.
In conclusion, dietary supplementation with PHGG in
hamsters fed with high-fat diet reduced plasma choles-
terol and lipid profiles and increased antioxidant Bcl-2
and HSP-70 protein expression in the vessels. High dose
of PHGG was more potent than low dose of PHGG in all
these effects. Our study further demonstrated that PHGG
inhibit FeCl3  enhanced oxidative stress and ICAM-1
expression and delay arterial thrombus formation in ham-
sters fed with high-fat diet. The clinical implications of
these findings are enormous in terms of recommending
supplementation of commercial antioxidant diet fibril to
patients with vascular disease or those at high risk of
developing it.
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